Company CVAbout Nectar Lifescience Ltd 
Nectar Lifescience Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Nectar Lifescience Limited was incorporated on June 27, 1995 with the name 'Surya Medicare Limited'. On March 26, 2004, Company changed their name from 'Surya Medicare Limited' to 'Nectar Lifescience Limited'. NECLIFE is an integrated pharmaceutical organization, engaged in manufacturing and delivering high quality pharmaceutical products. It is a global pharmaceutical company specializing in Cephalosporins.
Company Coordinates
Company Details
Village Saidpura, Tehsil Derabassi S A S Nagar Mohali Punjab : 140507
Registrar Details
Karvy Computershare Pvt Ltd., Karvy Selenium, Tower-B Plot No 31 & 32, Survey No 116/22, 115/24, 115/25, Financial District, Nanakramguda, Serilingampally, Mandal Ranga Reddy Dist, Hyderabad
Capital StructureCapital Structure
Present Equity Capital
INR 22.43 Cr
Number of Shares
22.43 Cr
Face Value
INR 1.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
26-Feb-2010
22.43
22.43
46000000
1
GDR
26-Feb-2010
22.43
22.43
46000000
1
GDR
20-Feb-2010
17.83
17.83
26000000
1
Allotment of Equity To Others
20-Feb-2010
17.83
17.83
26000000
1
Allotment of Equity To Others
12-Nov-2008
15.23
15.23
137034873
1
Stock Split
12-Nov-2008
15.23
15.23
137034873
1
Stock Split
07-Jan-2008
1.52
15.23
339430
10
FCCB
07-Jan-2008
1.52
15.23
339430
10
FCCB
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Non Institution
Pledged Promoter Holdings
98.7702
Mutual Funds
Held by 2 Schemes (0.0%)
FIIs
Held by 9 FIIs (0.62%)
Promoter with highest holding
Sanjiv Goyal (24.9%)
Highest Public shareholder
Jaideep Sampat (1.78%)
Individual Investors Holdings
44.7%
Board of Directors
Management
Designation
Remuneration
Sanjiv Goyal
Chairman & Managing Director
2.05 cr
Ajay Swaroop
Independent Director
1.25 lacs
Meena Verma
Nominee
80.0 k
Rupinder Tewari
Independent Director
1.55 lacs
Anubha
Company Sec. & Compli. Officer
0
Kuldip Kumar Bhasin
Independent Director
1.55 lacs
Indu Pal Kaur
Independent Director
95.0 k
Puneet Sud
Director (Operation)
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Traded Goods
52.35
1.68%
Traded Goods
Traded Goods
Stock DNARevenue and Profits:
Net Sales:
6 Cr
(Quarterly Results - Sep 2025)
Net Profit:
-176 Cr
Pharmaceuticals & Biotechnology
INR 473 Cr (Micro Cap)
NA (Loss Making)
34
0.00%
0.63
-17.19%
0.66
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
